haku: @all company restructuring / yhteensä: 162
viite: 159 / 162
| Tekijä: | Syedain, H. |
| Otsikko: | SmithKline Beecham`s early trials. |
| Lehti: | Management Today
1989 : NOV, p. 99-104 |
| Asiasana: | MERGERS PHARMACEUTICAL INDUSTRY |
| Kieli: | eng |
| Tiivistelmä: | Two firms, the American SmithKline Corporation and the British Beacham have merged. The merger comes against a background of consolidation within the pharmaceutical industry. With the upward pressure on costs, there is a downward pressure on drug prices. The third factor is the increase in generic drug manufacturers. In SmithKline a radical restructuring programme was initiated involving a write-down of assets, the closure of a plant and staff reductions. The product portfolios and research pipelines of the two companies fit together very well. Consumer products side gives the company a better chance for consistent profit flow. |
SCIMA